Corticoid treatment and SARS-CoV-2 variants: two independent factors associated with COVID-19 mortality in a Spanish regional hospital
CONCLUSIONS: This study confirms the therapeutic utility of glucocorticoids to reduce in-hospital mortality due to COVID-19. Heterogeneous mortality rates between the different COVID-19 waves suggest a direct role of viral variants as determinants of lethality, regardless of the patient's history.PMID:37203319 | PMC:PMC10205026 | DOI:10.23938/ASSN.1017
Source: Anales del Sistema Sanitario de Navarra - Category: General Medicine Authors: Juan Salas Jarque Javier Moreno D íaz Cristina Bustos Morell Javier Pereira Boan Antonio Dur án Portella Francisco Ruiz Montes Jos é Velilla Marco Source Type: research
More News: 1918 Spanish Flu | Cardiology | Chronic Obstructive Pulmonary | COVID-19 | Dementia | Epidemiology | General Medicine | Heart | Heart Failure | Hypertension | Microbiology | Pandemics | Renal Failure | SARS | Spain Health | Stroke | Study